SCHEMBL7989481

SCHEMBL7989481

Cc1cc2cc3c(C)c(CO)c(=O)oc3c(C)c2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAOA P21397 1/20 0.54
HTR2C P28335 1/20 0.54
MAPK1 P28482 1/20 0.54
ADORA2A P29274 1/20 0.54
GLA P06280 2/20 0.42
GAA P10253 2/20 0.42
KLK7 P49862 1/20 0.42
ATM Q13315 1/20 0.42
GPR35 Q9HC97 1/20 0.42
POLB P06746 6/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
CTDSP1 Q9GZU7 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL756454 0.85 ALDH1A1 (0.54) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL10588182 0.85 ALDH1A1 (0.54) KDM4EALDH1A1CYP1A2CYP3A4MAOA
Hydrochloric Acid SCHEMBL6991180 0.84 ALDH1A1 (0.52) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL11408643 0.84 ALDH1A1 (0.52) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL7632180 0.83 ALDH1A1 (0.51) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL5011938 0.82 ALDH1A1 (0.65) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL6991692 0.78 MAPK1 (0.46) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL8504877 0.78 KDM4E (0.46) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL16872346 0.77 MAPK1 (0.58) KDM4EALDH1A1CYP1A2CYP3A4MAOA
SCHEMBL499204 0.77 ALDH1A1 (0.58) KDM4EALDH1A1CYP1A2CYP3A4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121560-B1 DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSIS DIMENSIONGEN (KY) 2024-07-10 EP disclosed
US-20240110239-A1 DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSIS DIMENSION GENOMICS INC (US) 2024-04-04 US disclosed
US-11802312-B2 Devices and methods for multi-dimensional genome analysis Dimension Genomics Inc. 2023-10-31 US disclosed
US-20230193382-A1 DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSIS Dimension Genomics Inc. (US) 2023-06-22 US disclosed
CN-115803460-A Apparatus and method for multidimensional genomic analysis 德迈逊科技有限公司 2023-03-14 CN disclosed
EP-4121560-A1 DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSIS Dimensiongen (KY) 2023-01-25 EP disclosed
WO-2022035729-A1 DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSIS DIMENSIONGEN (KY) 2022-02-17 WO disclosed
US-20210317506-A1 CHEMICAL PLATFORM ASSISTED PROXIMITY CAPTURE (CAP-C) THE UNIVERSITY OF CHICAGO (US) 2021-10-14 US disclosed
EP-3799868-A1 PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN Galderma Research & Development (FR) 2021-04-07 EP disclosed
CN-112384524-A Chemical platform assisted proximity Capture (CAP-C) 芝加哥大学 2021-02-19 CN disclosed
EP-3082788-B1 PULSE PHOTODYNAMIC TREATMENT OF ACNE GALDERMA RES & DEV (FR) 2018-11-21 EP disclosed
EP-3082787-A1 PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN Galderma Research & Development (FR) 2016-10-26 EP disclosed
US-20160287701-A1 PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-10-06 US disclosed
WO-2015091037-A1 PULSE PHOTODYNAMIC TREATMENT OF PHOTODAMAGED SKIN GALDERMA RESEARCH & DEVELOPMENT (FR) 2015-06-25 WO disclosed
EP-0782388-A4 PHOTODYNAMIC INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS WITH HALOGENATED COUMARIN AND FUROCOUMARIN SENSITIZERS BAXTER INT (US) 2000-03-08 EP disclosed
US-5854967-A Device and method for photoactivation CERUS CORPORATION (US) 1998-12-29 US disclosed
WO-1997036581-A9 PHOTOPHERESIS TREATMENT OF LEUKOCYTES 1997-12-04 WO disclosed
EP-0782388-A1 PHOTODYNAMIC INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS WITH HALOGENATED COUMARIN AND FUROCOUMARIN SENSITIZERS BAXTER INTERNATIONAL INC. (US) 1997-07-09 EP disclosed
WO-1996008965-A1 PHOTODYNAMIC INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS WITH HALOGENATED COUMARIN AND FUROCOUMARIN SENSITIZERS BAXTER INTERNATIONAL, INC. (US) 1996-03-28 WO disclosed
EP-0333606-A2 Preparation of T-cell and T-cell membrane for use in prevention and treatment of autoimmune diseases YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) 1989-09-20 EP disclosed